scholarly article | Q13442814 |
P2093 | author name string | Grace Macalino | |
Jennifer Adelson Mitty | |||
Michael Sands | |||
Timothy Flanigan | |||
Valerie E Stone | |||
P2860 | cites work | Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group | Q29614934 |
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel | Q33824632 | ||
Safety and pharmacokinetics of once-daily regimens of soft-gel capsule saquinavir plus minidose ritonavir in human immunodeficiency virus-negative adults | Q33980711 | ||
Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults | Q33983070 | ||
Tuberculosis in New York City--turning the tide | Q34059053 | ||
Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice | Q34340996 | ||
Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel | Q41739646 | ||
Directly observed therapy in HIV therapy: A realistic perspective? | Q44026382 | ||
Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team | Q44088437 | ||
Community-based approaches to HIV treatment in resource-poor settings | Q44511047 | ||
Expanding directly observed therapy: tuberculosis to human immunodeficiency virus | Q45737148 | ||
Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients | Q45741363 | ||
Modified directly observed therapy for treatment of human immunodeficiency virus | Q45746719 | ||
Medication adherence strategies for drug abusers with HIV/AIDS. | Q45940723 | ||
Provider assessment of adherence to HIV antiretroviral therapy. | Q45962921 | ||
An open-label pilot study of the efficacy and tolerability of once-daily didanosine versus twice-daily didanosine. | Q53947558 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 984-990 | |
P577 | publication date | 2002-02-27 | |
P1433 | published in | Clinical Infectious Diseases | Q5133764 |
P1476 | title | Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress | |
P478 | volume | 34 |
Q36959607 | 30 Years on Selected Issues in the Prevention of HIV among Persons Who Inject Drugs |
Q38130928 | Achieving rapid reduction of HIV-1 viral load in HIV-positive pregnant women close to term - an obstetric/medical emergency: a review of three cases |
Q44921660 | Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting |
Q36065237 | Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users |
Q37136345 | Attitudes to directly observed antiretroviral treatment in a workplace HIV care programme in South Africa |
Q37136564 | Barriers to hepatitis C virus treatment in a Canadian HIV-hepatitis C virus coinfection tertiary care clinic |
Q35108744 | Challenges in delivering antiretroviral treatment in resource poor countries |
Q36248580 | Clinical care of the HIV-infected drug user |
Q58284501 | Community outreach with weekly delivery of anti-retroviral drugs compared to cognitive-behavioural health care team-based approach to improve adherence among indigent women newly starting HAART |
Q45497521 | Delivering care to injection drug users coinfected with HIV and hepatitis C virus |
Q42248267 | Direct monthly highly active antiretroviral therapy supply - a method to increase patient's adherence and outcome. Experience of one AIDS centre in Israel |
Q30497684 | Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: A randomized controlled trial |
Q53237430 | Directly observed highly active antiretroviral therapy for HIV-infected children in Cambodia. |
Q45000369 | Directly observed therapy (DOT): from tuberculosis to HIV |
Q76402213 | Directly observed therapy for HIV/tuberculosis co-infection |
Q43757922 | Efficacy of directly observed treatment of HIV infection: experience in AIDS welfare homes. |
Q33817807 | Equitable access to HCV care in HIV-HCV co-infection can be achieved despite barriers to health care provision |
Q35946490 | Expanding antiretroviral therapy in Malawi: drawing on the country's experience with tuberculosis |
Q36174500 | Facilitating adherence to highly active antiretroviral therapy in children with HIV infection: what are the issues and what can be done? |
Q33204461 | HIV/AIDS in Asia |
Q36049490 | Impact of adherence counseling dose on antiretroviral adherence and HIV viral load among HIV-infected methadone maintained drug users |
Q37020566 | Improving care for urban children with asthma: design and methods of the School-Based Asthma Therapy (SBAT) trial |
Q40307960 | Justifications for Non-Consensual Medical Intervention: From Infectious Disease Control to Criminal Rehabilitation |
Q28474749 | Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004 |
Q79327986 | Management of Antiretroviral Therapy in Neonates, Children, and Adolescents |
Q36223761 | Management of antiretroviral therapy in neonates, children, and adolescents |
Q44440794 | Optimizing the care of minority patients with HIV/AIDS. |
Q39677370 | Pharmaceutical care for HIV patients on directly observed therapy |
Q36272498 | Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users |
Q43752658 | Provider barriers to prescribing HAART to medically-eligible HIV-infected drug users |
Q36719674 | Recommendations in pediatric antiretroviral therapy |
Q44442989 | Strategies to optimize adherence to antiretroviral treatment. Interventions in the therapeutic regimen |
Q37221318 | Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial |
Q46413332 | The acceptability of a directly-administered antiretroviral therapy (DAART) intervention among patients in public HIV clinics in Los Angeles, California |
Q33559823 | The cost-effectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant women |
Q38954109 | Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients |
Q33813097 | Treatment Options for HIV-Associated Tuberculosis |
Search more.